Transcripts
Dexcom (DXCM) earnings call transcripts
Earnings call transcripts for Dexcom, with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
Dexcom framed Q2 as broad-based execution supporting a larger reimbursement-led growth runway, with product adoption and operating leverage tracking ahead of plan. 9 million U.S.
Jul 30, 2026Confident0.82